Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer

Sylvie Dubois-Marshall, Jeremy S. Thomas, Dana Faratian, David J. Harrison, Elad Katz

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


Epithelial to mesenchymal transition (EMT) occurs in embryogenesis and normal development. It has been predominantly described in vitro and in animal studies, but EMT is also implicated in the progression of many cancers with proposed roles in invasion, metastasis and resistance to treatment. It is closely associated with loss of epithelial-specific protein expression and up-regulation of mesenchymal proteins, but several pathways are implicated in its execution. We explored what are the expression patterns of EMT proteins in human breast cancer. We interrogated two independent cohorts enriched for high-grade, invasive, ductal breast cancers. We used quantitative immunofluorescence to study the expression of key EMT proteins. Statistical associations to define protein profiles were based on Pearson's correlations. E-cadherin down-regulation in breast cancer was associated with beta-catenin down-regulation, but not with up-regulation of mesenchymal markers. While EMT-related transcription repressors were expressed in some breast cancers, their expression did not negatively correlate with E-cadherin. Instead, an additional EMT profile was identified, composing Snail and Slug. In conclusion, EMT occurs in human breast cancer in a manner distinct to that seen in vitro. Certain EMT events are uncoupled from E-cadherin down-regulation and may constitute a novel EMT profile, which warrants further exploration.

Original languageEnglish
Pages (from-to)811-818
Number of pages8
JournalClinical & Experimental Metastasis
Issue number8
Publication statusPublished - Dec 2011


Dive into the research topics of 'Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer'. Together they form a unique fingerprint.

Cite this